Tags

Type your tag names separated by a space and hit enter

Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy.
Support Care Cancer. 2006 Nov; 14(11):1152-6.SC

Abstract

GOALS OF WORK

To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy.

PATIENTS AND METHODS

An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients.

MAIN RESULTS

According to PG-SGA global rating, the prevalence of malnutrition was 26%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100% sensitivity, 92% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001).

CONCLUSION

The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population.

Authors+Show Affiliations

Flinders University, Adelaide, SA, Australia. elisabeth.isenring@flinders.edu.auNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16622648

Citation

Isenring, Elisabeth, et al. "Validity of the Malnutrition Screening Tool as an Effective Predictor of Nutritional Risk in Oncology Outpatients Receiving Chemotherapy." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 14, no. 11, 2006, pp. 1152-6.
Isenring E, Cross G, Daniels L, et al. Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer. 2006;14(11):1152-6.
Isenring, E., Cross, G., Daniels, L., Kellett, E., & Koczwara, B. (2006). Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 14(11), 1152-6.
Isenring E, et al. Validity of the Malnutrition Screening Tool as an Effective Predictor of Nutritional Risk in Oncology Outpatients Receiving Chemotherapy. Support Care Cancer. 2006;14(11):1152-6. PubMed PMID: 16622648.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. AU - Isenring,Elisabeth, AU - Cross,Giordana, AU - Daniels,Lynne, AU - Kellett,Elizabeth, AU - Koczwara,Bogda, Y1 - 2006/04/19/ PY - 2006/2/21/received PY - 2006/3/22/accepted PY - 2006/4/20/pubmed PY - 2007/3/1/medline PY - 2006/4/20/entrez SP - 1152 EP - 6 JF - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer JO - Support Care Cancer VL - 14 IS - 11 N2 - GOALS OF WORK: To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy. PATIENTS AND METHODS: An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients. MAIN RESULTS: According to PG-SGA global rating, the prevalence of malnutrition was 26%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100% sensitivity, 92% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001). CONCLUSION: The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population. SN - 0941-4355 UR - https://www.unboundmedicine.com/medline/citation/16622648/full_citation DB - PRIME DP - Unbound Medicine ER -